Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

P53 mutations and other prognostic factors of renal cell carcinoma.

Urologia internationalis - 1 Jan 2001

Girgin C, Tarhan H, Hekimgil M, Sezer A, Gürel G

Abstract excerpt

OBJECTIVE: Tumor stage, histological pattern, cell type, diameter and cell ploidy are the factor that have been proposed for predicting the prognosis of renal cell carcinoma (RCC). There is a wide variation in the reported incidence of p53 mutation in RCC, and its prognostic significance for this tumor is unknown. We investigated the prognostic value of p53 mutations among other prognostic factors. PATIENTS AND...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Renal Cell

Share to Genes, p53

Share to Kidney Neoplasms

Share to Prognosis

Share to Survival Rate

Source

Identifiers

PMID: 11223748
DOI: 10.1159/000056575

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

P53 mutations and other prognostic factors of renal cell carcinoma.PMID 11223748Read ↗

Clinical significance of immunohistochemically detectable p53 protein in renal cell carcinoma.Semantic proximity Read ↗

p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?Semantic proximity Read ↗

Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma.Semantic proximity Read ↗

p53 and HER-2 alterations in renal cell carcinoma.Semantic proximity Read ↗

Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma.Semantic proximity Read ↗

Predictive role of vascular endothelial growth factor polymorphisms in the survival of renal cell carcinoma patients.Semantic proximity Read ↗

p53β: a new prognostic marker for patients with clear-cell renal cell carcinoma from 5.3 years of median follow-upSemantic proximity Read ↗

p53 is Functionally Inhibited in Clear Cell Renal Cell Carcinoma (Ccrcc): A Mechanistic and Correlative Investigation into Genetic and Molecular Characteristics.Semantic proximity Read ↗

Selected immunohistochemical features of conventional renal cell carcinomas coexpressing P53 and MDM2.Semantic proximity Read ↗

Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray studySemantic proximity Read ↗

p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics.Semantic proximity Read ↗

P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.